August 2024

NEUROSCIENCES

CASE REPORT: IDH-MUTANT GRADE II OLIGODENDROGLIOMA

Northwestern Medicine Neuro-oncologist Karan S. Dixit, MD, presents the case of a 35-year-old patient with IDH mutant 1p/19q oligodendroglioma and explains the rationale behind opting for observation over adjuvant therapy after surgery.
Karan Dixit, MD, assistant professor in the Ken and Ruth Davee Department of Neurology’s Divisions of Neuro-oncology and Hospital Neurology.

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. 

You May Also Like